Immunoprecise Antibodies Stock Forecast - Naive Prediction

IPA Stock  USD 1.24  0.03  2.36%   
The Naive Prediction forecasted value of Immunoprecise Antibodies on the next trading day is expected to be 1.19 with a mean absolute deviation of  0.08  and the sum of the absolute errors of 4.78. Immunoprecise Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Immunoprecise Antibodies stock prices and determine the direction of Immunoprecise Antibodies's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Immunoprecise Antibodies' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Immunoprecise Antibodies' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Immunoprecise Antibodies' systematic risk associated with finding meaningful patterns of Immunoprecise Antibodies fundamentals over time.
Check out Historical Fundamental Analysis of Immunoprecise Antibodies to cross-verify your projections.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
  
As of April 18, 2024, Inventory Turnover is expected to decline to 4.83. In addition to that, Payables Turnover is expected to decline to 2.75. The current year's Common Stock Shares Outstanding is expected to grow to about 30.1 M, whereas Net Loss is projected to grow to (22.7 M).

Open Interest Against 2024-04-19 Immunoprecise Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Immunoprecise Antibodies' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Immunoprecise Antibodies' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Immunoprecise Antibodies stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Immunoprecise Antibodies' open interest, investors have to compare it to Immunoprecise Antibodies' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Immunoprecise Antibodies is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Immunoprecise. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Immunoprecise Antibodies cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Immunoprecise Antibodies' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Immunoprecise Antibodies' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for Immunoprecise Antibodies is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Immunoprecise Antibodies value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Immunoprecise Antibodies Naive Prediction Price Forecast For the 19th of April

Given 90 days horizon, the Naive Prediction forecasted value of Immunoprecise Antibodies on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.78.
Please note that although there have been many attempts to predict Immunoprecise Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Immunoprecise Antibodies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Immunoprecise Antibodies Stock Forecast Pattern

Backtest Immunoprecise AntibodiesImmunoprecise Antibodies Price PredictionBuy or Sell Advice 

Immunoprecise Antibodies Forecasted Value

In the context of forecasting Immunoprecise Antibodies' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Immunoprecise Antibodies' downside and upside margins for the forecasting period are 0.01 and 7.14, respectively. We have considered Immunoprecise Antibodies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.24
1.19
Expected Value
7.14
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Immunoprecise Antibodies stock data series using in forecasting. Note that when a statistical model is used to represent Immunoprecise Antibodies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.6052
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0783
MAPEMean absolute percentage error0.0449
SAESum of the absolute errors4.7775
This model is not at all useful as a medium-long range forecasting tool of Immunoprecise Antibodies. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Immunoprecise Antibodies. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Immunoprecise Antibodies

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunoprecise Antibodies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.247.19
Details
Intrinsic
Valuation
LowRealHigh
0.152.928.87
Details
2 Analysts
Consensus
LowTargetHigh
7.277.998.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunoprecise Antibodies. Your research has to be compared to or analyzed against Immunoprecise Antibodies' peers to derive any actionable benefits. When done correctly, Immunoprecise Antibodies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Immunoprecise Antibodies.

Other Forecasting Options for Immunoprecise Antibodies

For every potential investor in Immunoprecise, whether a beginner or expert, Immunoprecise Antibodies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immunoprecise Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immunoprecise. Basic forecasting techniques help filter out the noise by identifying Immunoprecise Antibodies' price trends.

Immunoprecise Antibodies Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunoprecise Antibodies stock to make a market-neutral strategy. Peer analysis of Immunoprecise Antibodies could also be used in its relative valuation, which is a method of valuing Immunoprecise Antibodies by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Immunoprecise Antibodies Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Immunoprecise Antibodies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Immunoprecise Antibodies' current price.

Immunoprecise Antibodies Market Strength Events

Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns.

Immunoprecise Antibodies Risk Indicators

The analysis of Immunoprecise Antibodies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immunoprecise Antibodies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immunoprecise stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunoprecise Antibodies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunoprecise Antibodies' short interest history, or implied volatility extrapolated from Immunoprecise Antibodies options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Immunoprecise Antibodies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunoprecise Antibodies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunoprecise Antibodies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunoprecise Antibodies Stock:
Check out Historical Fundamental Analysis of Immunoprecise Antibodies to cross-verify your projections.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.939
Quarterly Revenue Growth
0.203
Return On Assets
(0.11)
Return On Equity
(0.26)
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.